Bonnie Brehm

Bonnie Brehm

Auto-generated profile, based on publicly available information

Bonnie Brehm

Department of Population Health, College of Nursing, University of Cincinnati, Cincinnati, US

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2020 in Research in Nursing & Health
Verified
Journal Article
Closed access
PDF file
TBTamilyn Bakas
Tamilyn Bakas
MMMichael J. McCarthy
Michael J. McCarthy
JIJahmeel Israel
Jahmeel Israel
BBBonnie J. Brehm
Bonnie J. Brehm
KDKari Dunning
Kari Dunning
EMElaine Linda Miller
Elaine Linda Miller

25 March 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
TBTamilyn Bakas
Tamilyn Bakas
EMElaine Linda Miller
Elaine Linda Miller
HSHeidi Sucharew
Heidi Sucharew
NKNatalie Kreitzer
Natalie Kreitzer
JIJahmeel Israel
Jahmeel Israel
PMPamela H Mitchell
Pamela H Mitchell
Background: Stroke is a leading cause of serious, long-term disability and has a sudden onset. Upon discharge to the home setting, families are thrust into providing care, often without sufficient training from health care providers. Aligned with current patient and caregiver guidelines, the Telehealth Assessment and Skill-Building Kit (TASK III) is a nurse-led intervention designed to empower caregivers to address their own needs and those of the survivor using innovative skill-building strategies. Objective: This study aims to test the short-term (immediately after the intervention at 8 wk) and long-term (12, 24, and 52 wk) efficacy of the TASK III intervention, compared with an information, support, and referral (ISR) group, to improve caregiver life changes (ie, changes in physical health, physical functioning, emotional well-being, and general health) as a result of providing care. Methods: A randomized controlled clinical trial design will be used with baseline data collection from 296 family caregivers by telephone after the stroke survivor is discharged home. Caregivers randomly assigned to the ISR group (n=148, 50%) will receive information from the American Heart Association about stroke family caregiving. Caregivers randomly assigned to the TASK III group (n=148, 50%) will receive a TASK III resource guide and information from the American Heart Association. Both groups will receive 8 weekly calls from a nurse, with a booster call a month later. Outcomes will be assessed by blinded data collectors at 8, 12, 24, and 52 weeks. The primary outcome (at 8 wk) is caregiver life changes measured by the Bakas Caregiving Outcomes Scale. Secondary outcomes are depressive symptoms; other symptoms (eg, stress, fatigue, sleep, pain, and shortness of breath); unhealthy days; diet; exercise; and self-reported health care use. Mediators are task difficulty, threat appraisal, and self-efficacy. Program evaluation outcomes (satisfaction and technology ratings) will also be analyzed. Results: The trial was registered on March 10, 2022. Enrollment and random assignment of the first participant was on November 30, 2022, with an anticipated completion of recruitment by November 30, 2025. Completion of the primary end point data analysis is anticipated by August 31, 2026, with results expected to be reported on ClinicalTrials.gov by April 1, 2027. As of October 9, 2024, a total of 198 (66.9% of the proposed total sample of 296) family caregivers have been enrolled and randomly assigned to the TASK III group (n=98, 49.5%) or the ISR group (n=100, 50.5%). The last update was performed on January 25, 2024. Conclusions: If the TASK III intervention is shown to be efficacious in the proposed randomized controlled clinical trial, our next goal will be to translate TASK III into ongoing stroke systems of care, providing a tremendous public health impact. Trial Registration: ClinicalTrials.gov NCT05304078; https://clinicaltrials.gov/study/NCT05304078 International Registered Report Identifier (IRRID): DERR1-10.2196/67219

28 February 2024 in American Journal of Pharmaceutical Education
Verified
Journal Article
Open access
BBBonnie Brehm
Bonnie Brehm
PBPhyllis Breen
Phyllis Breen
BBBethanne Brown
Bethanne Brown
LLLisa Long
Lisa Long
RSRebecca Smith
Rebecca Smith
NWNancy Steinberg Warren
Nancy Steinberg Warren

10 October 2024 in JMIR Preprints
Verified
Preprint
Open access
TBTamilyn Bakas
Tamilyn Bakas
EMElaine Linda Miller
Elaine Linda Miller
HSHeidi Sucharew
Heidi Sucharew
NKNatalie Kreitzer
Natalie Kreitzer
JIJahmeel Israel
Jahmeel Israel
PMPamela H Mitchell
Pamela H Mitchell
BACKGROUND Stroke is a leading cause of serious, long-term disability and has a sudden onset. Upon discharge to the home setting, families are thrust into providing care, often without sufficient training from health care providers. Aligned with current patient and caregiver guidelines, the Telehealth Assessment and Skill-Building Kit (TASK III) is a nurse-led intervention designed to empower caregivers to address their own needs and those of the survivor using innovative skill-building strategies. OBJECTIVE This study aims to test the short-term (immediately after the intervention at 8 wk) and long-term (12, 24, and 52 wk) efficacy of the TASK III intervention, compared with an information, support, and referral (ISR) group, to improve caregiver life changes (ie, changes in physical health, physical functioning, emotional well-being, and general health) as a result of providing care. METHODS A randomized controlled clinical trial design will be used with baseline data collection from 296 family caregivers by telephone after the stroke survivor is discharged home. Caregivers randomly assigned to the ISR group (n=148, 50%) will receive information from the American Heart Association about stroke family caregiving. Caregivers randomly assigned to the TASK III group (n=148, 50%) will receive a TASK III resource guide and information from the American Heart Association. Both groups will receive 8 weekly calls from a nurse, with a booster call a month later. Outcomes will be assessed by blinded data collectors at 8, 12, 24, and 52 weeks. The primary outcome (at 8 wk) is caregiver life changes measured by the Bakas Caregiving Outcomes Scale. Secondary outcomes are depressive symptoms; other symptoms (eg, stress, fatigue, sleep, pain, and shortness of breath); unhealthy days; diet; exercise; and self-reported health care use. Mediators are task difficulty, threat appraisal, and self-efficacy. Program evaluation outcomes (satisfaction and technology ratings) will also be analyzed. RESULTS The trial was registered on March 10, 2022. Enrollment and random assignment of the first participant was on November 30, 2022, with an anticipated completion of recruitment by November 30, 2025. Completion of the primary end point data analysis is anticipated by August 31, 2026, with results expected to be reported on ClinicalTrials.gov by April 1, 2027. As of October 9, 2024, a total of 198 (66.9% of the proposed total sample of 296) family caregivers have been enrolled and randomly assigned to the TASK III group (n=98, 49.5%) or the ISR group (n=100, 50.5%). The last update was performed on January 25, 2024. CONCLUSIONS If the TASK III intervention is shown to be efficacious in the proposed randomized controlled clinical trial, our next goal will be to translate TASK III into ongoing stroke systems of care, providing a tremendous public health impact. CLINICALTRIAL ClinicalTrials.gov NCT05304078; https://clinicaltrials.gov/study/NCT05304078 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67219

1 September 2001 in Journal of the American Dietetic Association
Verified
Journal Article
Closed access
BBB.J. Brehm
B.J. Brehm
SCS.C. Couch
S.C. Couch
BLB.L. Lattin
B.L. Lattin